MedPath

云南植物药业有限公司

Ownership
-
Established
1998-10-26
Employees
-
Market Cap
-
Website
http://www.yzyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

339

NMPA:339

Drug Approvals

Vinorelbine Tartrate Injection

Product Name
酒石酸长春瑞滨注射液
Approval Number
国药准字H20093475
Approval Date
Mar 18, 2024
NMPA

Paclitaxel Injection

Product Name
紫杉醇注射液
Approval Number
国药准字H20093882
Approval Date
Mar 18, 2024
NMPA

降脂宁片

Approval Number
国药准字Z20090645
Approval Date
Oct 25, 2023
NMPA

独一味滴丸

Approval Number
国药准字Z20090699
Approval Date
Sep 4, 2023
NMPA

老年咳喘片

Approval Number
国药准字Z20083359
Approval Date
Jul 24, 2023
NMPA

银黄滴丸

Approval Number
国药准字Z20080191
Approval Date
Nov 3, 2022
NMPA

Clindamycin Phosphate Gel

Product Name
克林霉素磷酸酯凝胶
Approval Number
国药准字H20066877
Approval Date
May 28, 2021
NMPA

益肝灵滴丸

Approval Number
国药准字Z20113023
Approval Date
Jan 6, 2021
NMPA

Cefalexin Tablets

Product Name
头孢氨苄片
Approval Number
国药准字H53020390
Approval Date
Sep 30, 2020
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H53020603
Approval Date
Sep 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 34
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.